Open Access. Powered by Scholars. Published by Universities.®
Medicinal and Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Other Pharmacy and Pharmaceutical Sciences (10)
- Medical Sciences (8)
- Life Sciences (7)
- Chemicals and Drugs (6)
- Diseases (6)
-
- Medical Specialties (4)
- Pharmaceutics and Drug Design (4)
- Biochemistry, Biophysics, and Structural Biology (3)
- Chemical and Pharmacologic Phenomena (3)
- Medical Education (3)
- Organic Chemicals (3)
- Amino Acids, Peptides, and Proteins (2)
- Bacteria (2)
- Biochemistry (2)
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Chemistry (2)
- Heterocyclic Compounds (2)
- Medical Biochemistry (2)
- Medical Pharmacology (2)
- Medicinal Chemistry and Pharmaceutics (2)
- Natural Products Chemistry and Pharmacognosy (2)
- Oncology (2)
- Organisms (2)
- Other Chemicals and Drugs (2)
- Pharmacology, Toxicology and Environmental Health (2)
- Physical Sciences and Mathematics (2)
- Translational Medical Research (2)
- Institution
-
- Chapman University (7)
- Virginia Commonwealth University (5)
- Technological University Dublin (3)
- University of Tennessee Health Science Center (3)
- Marshall University (2)
-
- Parkland College (2)
- Butler University (1)
- Harrisburg University of Science and Technology (1)
- Loma Linda University (1)
- Seton Hall University (1)
- The University of Akron (1)
- The University of Southern Mississippi (1)
- Touro College and University System (1)
- University of Connecticut (1)
- University of Kentucky (1)
- University of Louisville (1)
- University of Nebraska Medical Center (1)
- Keyword
-
- Antibiotics (2)
- Kidney (2)
- Lung cancer (2)
- NSAIDs (2)
- Nanoparticles (2)
-
- Pharmacokinetics (2)
- Pharmacy (2)
- 5-HT3 receptors (1)
- Adverse drug reactions (1)
- Allosteric modulator (1)
- Alzheimer's disease (1)
- Amixicile (1)
- Amphiphilic polymers (1)
- Anti-apoptosis protein (1)
- Anti-cancer (1)
- Anti-tumor (1)
- Anticoagulants (1)
- Antimicrobial activity (1)
- Antiproliferative; anticancer; combretastatin A-4 (1)
- Antischistosomal agents (1)
- Asymmetric reactions; Assymetric bonds; Organocatalysts (1)
- Bis imidazolium salt (1)
- Blood (1)
- Breast cancer (1)
- Breast cancer therapy (1)
- C-H activation (1)
- Carbon nanotubes (1)
- Carcinogenesis (1)
- Celecoxib (1)
- Cell cycle protein (1)
- Publication
-
- Pharmacy Faculty Articles and Research (7)
- Theses and Dissertations (5)
- Theses and Dissertations (ETD) (3)
- Doctoral (2)
- Natural Sciences Student Research Presentations (2)
-
- Articles (1)
- Biochemistry and Microbiology (1)
- Doctoral Projects (1)
- Electronic Theses and Dissertations (1)
- Harrisburg University Faculty Works (1)
- Honors Scholar Theses (1)
- Loma Linda University Electronic Theses, Dissertations & Projects (1)
- Marshall Journal of Medicine (1)
- Scholarship and Professional Work – COPHS (1)
- Seton Hall University Dissertations and Theses (ETDs) (1)
- Theses & Dissertations (1)
- Theses and Dissertations--Toxicology and Cancer Biology (1)
- Touro Yearbooks (1)
- Williams Honors College, Honors Research Projects (1)
- Publication Type
Articles 31 - 33 of 33
Full-Text Articles in Medicinal and Pharmaceutical Chemistry
Examination Of The Pharmacodynamics And Pharmacokinetics Of A Diclofenac Poly(Lactic-Co-Glycolic) Acid Nanoparticle Formulation In The Rat, Sam Harirforoosh, Kelsi O. West, Derek E. Murrell, James W. Denham, Peter C. Panus, Greg A. Hanley
Examination Of The Pharmacodynamics And Pharmacokinetics Of A Diclofenac Poly(Lactic-Co-Glycolic) Acid Nanoparticle Formulation In The Rat, Sam Harirforoosh, Kelsi O. West, Derek E. Murrell, James W. Denham, Peter C. Panus, Greg A. Hanley
Pharmacy Faculty Articles and Research
OBJECTIVE: Nonsteroidal anti-inflammatory drugs (NSAIDs) are assembled into two categories; cyclooxygenase (COX-1) sparing inhibitors of COX-2 and non-selective NSAIDs. Diclofenac (DICLO) is a non-selective NSAID that has been linked to serious side effects including gastric ulcers and renal injury. In this study, we examine the effect of poly(lactic-co-glycolic) acid nanoformulation on DICLO-associated adverse events and pharmacokinetics using a nanoparticle (NP) formulation previously developed in our laboratory.
MATERIALS AND METHODS: Rats were administered a single dose of methylcellulose (VEH), blank NP, DICLO (10 mg/kg), or a DICLO-NP suspension equivalent to the DICLO dose. Urinary and blood parameters were measured …
Assessment Of Celecoxib Poly(Lactic-Co-Glycolic) Acid Nanoformulation On Drug Pharmacodynamics And Pharmacokinetics In Rats, Sam Harirforoosh, Kelsi O. West, Derek E. Murrell, James W. Denham, Peter C. Panus, Greg A. Hanley
Assessment Of Celecoxib Poly(Lactic-Co-Glycolic) Acid Nanoformulation On Drug Pharmacodynamics And Pharmacokinetics In Rats, Sam Harirforoosh, Kelsi O. West, Derek E. Murrell, James W. Denham, Peter C. Panus, Greg A. Hanley
Pharmacy Faculty Articles and Research
OBJECTIVE: Celecoxib (CEL) is a nonsteroidal anti-inflammatory drug (NSAID) showing selective cycloxygenase-2 inhibition. While effective as a pain reducer, CEL exerts some negative influence on renal and gastrointestinal parameters. This study examined CEL pharmacodynamics and pharmacokinetics following drug reformulation as a poly(lactic-co-glycolic) acid nanoparticle (NP).
MATERIALS AND METHODS: Rats were administered either vehicle (VEH) (methylcellulose solution), blank NP, 40 mg/kg CEL in methylcellulose, or an equivalent NP dose (CEL-NP). Plasma and urine (over 12 hrs) samples were collected prior to and post-treatment. The mean percent change from baseline of urine flow rate along with electrolyte concentrations in plasma …
Application Of Organ Clearance To Estimation Of The In Vivo Hepatic Extraction Ratio, Reza Mehvar
Application Of Organ Clearance To Estimation Of The In Vivo Hepatic Extraction Ratio, Reza Mehvar
Pharmacy Faculty Articles and Research
Organ clearance, which has been derived from the organ blood flow and extraction ratio (E), has been extensively used by clinical pharmacologists to explain the pharmacokinetics of many drugs in health and disease. For example, the extent of hepatic clearance or E (Eh) of drugs would determine their response to changes in the liver blood flow and/or activities of the metabolizing enzymes. Although Eh may be obtained directly by cannulating internal blood vessels, the method is invasive. Therefore, indirect methods have been used to estimate Eh from the peripheral blood concentration-time data after intravascular administration of …